Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement
Go back to Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement| Asianada, Inc. (NASDAQ: ASND) | Delayed: 239.70 -7.99 (3.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $247.69 | 52 Week High | $21.79 | |||
| Open | $249.23 | 52 Week Low | $11.92 | |||
| Day High | $249.23 | P/E | N/A | |||
| Day Low | $237.50 | EPS | $-0.07 | |||
| Volume | 439,477 | |||||
| REPROS THERAPEUTICS (NASDAQ: RPRX) | Delayed: 58.65 +0.18 (0.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $58.47 | 52 Week High | $3.48 | |||
| Open | $58.81 | 52 Week Low | $0.80 | |||
| Day High | $59.18 | P/E | N/A | |||
| Day Low | $58.46 | EPS | $-1.54 | |||
| Volume | 737,886 | |||||
